Andrea Sambati

Boehringer Ingelheim (Canada) Ltd. engages in the research and development of new drugs and medicines for the treatment of respiratory diseases. The firm offers therapeutic options for diseases and conditions, such as chronic obstructive pulmonary disease, high blood pressure, stroke, depression, benign prostatic hyperplasia, Parkinson's disease, virology, stroke prevention in atrial fibrillation, and diabetes. The company was founded in 1972 and is headquartered in Burlington, Canada.

Boehringer Ingelheim Animal Health Canada, Inc. provides disease prevention and health management in animals. The firm offers pharmaceutical products and vaccines for livestock, pets, and wildlife. The company is headquartered in Baie-d'Urfé, Canada.

Boehringer Ingelheim (Canada) Ltd. engages in the research and development of new drugs and medicines for the treatment of respiratory diseases. The firm offers therapeutic options for diseases and conditions, such as chronic obstructive pulmonary disease, high blood pressure, stroke, depression, benign prostatic hyperplasia, Parkinson's disease, virology, stroke prevention in atrial fibrillation, and diabetes. The company was founded in 1972 and is headquartered in Burlington, Canada.

Boehringer Ingelheim Animal Health Canada, Inc. provides disease prevention and health management in animals. The firm offers pharmaceutical products and vaccines for livestock, pets, and wildlife. The company is headquartered in Baie-d'Urfé, Canada.

Boehringer Ingelheim Animal Health Canada, Inc. provides disease prevention and health management in animals. The firm offers pharmaceutical products and vaccines for livestock, pets, and wildlife. The company is headquartered in Baie-d'Urfé, Canada.